Geron (GERN) Prepaid Assets (2010 - 2026)
Geron (GERN) posted Prepaid Assets of $6.9 million for Q1 2026, up 48.89% sequentially from $4.6 million in Q4 2025, and up 0.62% YoY from $6.8 million in Q1 2025.
Geron (GERN) Prepaid Assets (2010 - 2026) Analysis & Trends
Geron has reported Prepaid Assets for 17 years, with the latest figure at $6.9 million in Q1 2026.
- Quarterly Prepaid Assets rose 0.62% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (up 0.62% YoY) and the FY2025 annual result came in at $4.6 million, down 8.77% from the prior year.
- Prepaid Assets climbed to $6.9 million in Q1 2026 per GERN's latest filing, from $4.6 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $7.3 million in Q2 2025 and troughed at $3.5 million in Q2 2022.
- A 5-year average of $5.3 million and a median of $5.1 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets jumped 194.18% in 2022, then fell 8.77% in 2025.
- Over 5 years, Prepaid Assets stood at $4.0 million in 2022, then increased by 22.22% to $4.9 million in 2023, then advanced by 3.57% to $5.1 million in 2024, then retreated by 8.77% to $4.6 million in 2025, then jumped by 48.89% to $6.9 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $6.9 million, $4.6 million, and $6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.50 Mn |
| Mar 31, 2026 | 6.86 Mn |
| Dec 31, 2025 | 4.61 Mn |
| Sep 30, 2025 | 6.86 Mn |
| Jun 30, 2025 | 7.26 Mn |
| Mar 31, 2025 | 6.82 Mn |
| Dec 31, 2024 | 5.05 Mn |
| Sep 30, 2024 | 6.06 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Mar 31, 2024 | 5.71 Mn |
| Dec 31, 2023 | 4.88 Mn |
| Sep 30, 2023 | 6.27 Mn |
| Jun 30, 2023 | 4.18 Mn |
| Mar 31, 2023 | 4.32 Mn |
| Dec 31, 2022 | 3.99 Mn |
| Sep 30, 2022 | 4.70 Mn |
| Jun 30, 2022 | 3.47 Mn |
| Mar 31, 2022 | 3.65 Mn |
| Dec 31, 2021 | 1.36 Mn |
| Sep 30, 2021 | 2.26 Mn |